Acute Lung Injury
Conditions
Interventions
Treatment group:Conventional Western medical treatment plus Huangqin Decoction
Sponsors
Shanghai City Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria for sepsis-related ARDS in Western medicine and the criteria for disease differentiation and syndrome differentiation in traditional Chinese medicine, and voluntarily agree to participate in the treatment plan of this study. (2) Age >18 years, gender. (3) The informed consent process complies with regulations, and the patient agrees to participate in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) Age < 18 years; (2) Patients in the terminal stage of chronic diseases; patients with mental abnormalities; (3) Patients with malignant tumors, severe hepatic or renal dysfunction (cirrhosis, acute or chronic hepatitis, glomerulonephritis, nephrotic syndrome), active bleeding, thrombotic diseases (acute myocardial infarction, pulmonary embolism, acute cerebral infarction), or severe burns; (4) Patients with allergies to multiple drugs or allergic constitutions; (5) Patients currently participating in other clinical trials; (6) Patients with incomplete clinical data, imaging, or follow-up records; (7) Patients with low compliance. If any of the above answers is "yes," the patient cannot be enrolled.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Respiratory function index;Circulatory Perfusion Index;Inflammatory markers;Autophagy-related proteins;gut microbiota; | — |
Secondary
| Measure | Time frame |
|---|---|
| APACHE II score;SOFA Score;Murray Lung Injury Score;Traditional Chinese Medicine Syndrome Scoring; | — |
Countries
China
Contacts
Public ContactMai Jing Yin
Shanghai Municipal Hospital of Traditional Chinese Medicine
Outcome results
None listed